Baumann Ed. crosses the Atlantic with the MedTech Innovation Lab: a key step in its development and growth
The MedTech Innovation Lab – What is it?
The TransMedtech Institute’s MedTech Innovation Lab program is an open innovation space that helps startups and SMEs structure, develop, and commercialize their medical technologies in Quebec.
To objective is :
- To offer manufacturers, startups, SMEs, and innovation and entrepreneurship centers high value-added services, support, and coordination for the development and commercialization of innovations in medical technologies, in collaboration with the community, innovators, and opinion leaders, under real-world conditions.
- Optimize companies’ innovation and commercialization cycles by leveraging key players in the ecosystem and our living lab approach, with strong roots in healthcare settings and innovation hubs (partner hospitals, universities, accelerators, and incubators).
- To accelerate and de-risk the development, adoption, and commercialization cycles of healthcare innovations, in collaboration with key players in the ecosystem.
Illustration by example: Baumann Ed.
Who are Baumann Ed.?
Baumann Ed. offers practical solutions to support language development.
Rather than sticking to theoretical approaches, Baumann Ed. develops innovative solutions to support people with speech and swallowing difficulties. In concrete terms, this involves providing professionals and caregivers with shared protocols. These solutions can take the form of services such as training or hotlines, but also medical devices such as muscle structuring orthoses, as well as software that incorporates exercise protocols designed to promote language mastery and integrates artificial intelligence. The company strives to make visible what is often invisible: the mechanisms of language, how to identify and understand them, and ultimately how to support them effectively.
Why did they choose the MedTech Innovation Lab ?
The company aims to explore business opportunities in Quebec with a view to establishing itself in the North American market, targeting specific populations: pediatric prevention and geriatric treatment for maintaining functional abilities and for people who have suffered a stroke, among others.
In this context, it commissioned the TransMedTech Institute to assist it in identifying and meeting key partners in the ecosystem at the academic, industrial, and government levels. This support enables them to guide them in their strategic and business thinking for their development and growth.
“We are very pleased with this collaboration with the TransMedTech Institute, which has enabled us to identify and meet, in record time, numerous potential partners with a view to possibly establishing a presence in Canada. This support is invaluable to us, and we hope that it will lead to strong and lasting partnerships.” Raphaël Faleschini, Co-founder & Marketing Director, Baumann Ed.
If you are a medtech or digital health startup in development, we can help you. To learn more about the Medtech Innovation Lab, or contact us at: info.transmedtech@polymtl.ca
Source :
Géraldine Dumesnil
Communication Services,
Institut TransMedTech
